Randomized clinical trials in cardiac surgery: from necessity to difficulty
A commentary on a review article exploring the current state of randomized evidence and its role in advancing cardiac surgery.
A commentary on a review article exploring the current state of randomized evidence and its role in advancing cardiac surgery.
The American Board of Thoracic Surgery (ABTS) has formally adopted the 360° evaluation as an integral component of its certification process for thoracic surgeons, aiming to provide a more objective assessment of professional competence and nontechnical skills.
This Swedish retrospective observational study compares the long-term risk of cancer incidence in relation to the use or omission of cardiopulmonary bypass (CPB) during coronary artery bypass grafting (CABG).
This retrospective single-center study (Mayo Clinic) aimed to assess early and late outcomes of patients who underwent extended septal myectomy due to recurrent left ventricular outflow tract gradients following prior septal reduction therapy, either percutaneous (alcohol septal ablation) or surgical.
This meta-analysis of 28 studies sought to evaluate the prognostic impact of permanent pacemaker (PPM) implantation in the postoperative period of cardiac surgery, with a focus on surgical procedure type and device indication.
Consensus document on bleeding management, transfusion, and quality metrics in cardiac surgery
An analysis of the various factors that may influence the effectiveness of myocardial protection during cardiac surgery in patients with left ventricular ejection fraction (LVEF) below 40%, with a focus on comparing the efficacy of del Nido versus cold blood cardioplegia.
This article provides a comprehensive review of the current state of leadless cardiac pacing, tracing its historical evolution, analyzing the available evidence, and highlighting future challenges and expectations for this technology.
Pioneering meta-analysis summarizing the outcomes of endovascular treatment for benign and malignant occlusive venous disease in the upper body.
Pathophysiology and management of mitral regurgitation associated with hypertrophic obstructive cardiomyopathy